Literature DB >> 27080137

Diabetes mellitus and its complications in India.

Ranjit Unnikrishnan1, Ranjit Mohan Anjana1, Viswanathan Mohan1.   

Abstract

India is one of the epicentres of the global diabetes mellitus pandemic. Rapid socioeconomic development and demographic changes, along with increased susceptibility for Indian individuals, have led to the explosive increase in the prevalence of diabetes mellitus in India over the past four decades. Type 2 diabetes mellitus in Asian Indian people is characterized by a young age of onset and occurrence at low levels of BMI. Available data also suggest that the susceptibility of Asian Indian people to the complications of diabetes mellitus differs from that of white populations. Management of this disease in India faces multiple challenges, such as low levels of awareness, paucity of trained medical and paramedical staff and unaffordability of medications and services. Novel interventions using readily available resources and technology promise to revolutionise the care of patients with diabetes mellitus in India. As many of these challenges are common to most developing countries of the world, the lessons learnt from India's experience with diabetes mellitus are likely to be of immense global relevance. In this Review, we discuss the epidemiology of diabetes mellitus and its complications in India and outline the advances made in the country to ensure adequate care. We make specific references to novel, cost-effective interventions, which might be of relevance to other low-income and middle-income countries of the world.

Entities:  

Mesh:

Year:  2016        PMID: 27080137     DOI: 10.1038/nrendo.2016.53

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  141 in total

1.  Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study.

Authors:  R M Anjana; R Pradeepa; M Deepa; M Datta; V Sudha; R Unnikrishnan; A Bhansali; S R Joshi; P P Joshi; C S Yajnik; V K Dhandhania; L M Nath; A K Das; P V Rao; S V Madhu; D K Shukla; T Kaur; M Priya; E Nirmal; S J Parvathi; S Subhashini; R Subashini; M K Ali; V Mohan
Journal:  Diabetologia       Date:  2011-09-30       Impact factor: 10.122

2.  Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP).

Authors:  Ambady Ramachandran; Chamukuttan Snehalatha; Annasami Yamuna; Simon Mary; Zhang Ping
Journal:  Diabetes Care       Date:  2007-08-01       Impact factor: 19.112

3.  The Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study: methodological details.

Authors:  Ranjit Mohan Anjana; Rajendra Pradeepa; Mohan Deepa; Manjula Datta; Vasudevan Sudha; Ranjit Unnikrishnan; Lalith M Nath; Ashok Kumar Das; Sri Venkata Madhu; Paturi Vishnupriya Rao; Deepak Kumar Shukla; Tanvir Kaur; Mohammed K Ali; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

4.  Convergence of prevalence rates of diabetes and cardiometabolic risk factors in middle and low income groups in urban India: 10-year follow-up of the Chennai Urban Population Study.

Authors:  Mohan Deepa; Ranjit Mohan Anjana; Datta Manjula; K M Venkat Narayan; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

5.  Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India.

Authors:  V Mohan; R Meera; G Premalatha; R Deepa; P Miranda; M Rema
Journal:  Postgrad Med J       Date:  2000-09       Impact factor: 2.401

6.  Molecular mechanisms involved in the etiopathogenesis of malnutrition-modulated diabetes mellitus.

Authors:  A Kanungo; K C Samal; C B Sanjeevi
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

7.  Prevalence of diabetic complications in fibrocalculous pancreatic diabetic patients and type 2 diabetic patients: a cross-sectional comparative study.

Authors:  Karuna Kanta Barman; Mahesh Padmanabhan; Gopal Premalatha; Raj Deepa; Mohan Rema; Viswanathan Mohan
Journal:  J Diabetes Complications       Date:  2004 Sep-Oct       Impact factor: 2.852

8.  Overweight and diabetes prevalence among US immigrants.

Authors:  Reena Oza-Frank; K M Venkat Narayan
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

9.  Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.

Authors:  Rajeev Gupta; K K Sharma; Arvind Gupta; Aachu Agrawal; Indu Mohan; V P Gupta; R S Khedar; Soneil Guptha
Journal:  J Assoc Physicians India       Date:  2012-03

10.  Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK.

Authors:  N G Forouhi; N Sattar; T Tillin; P M McKeigue; N Chaturvedi
Journal:  Diabetologia       Date:  2006-09-14       Impact factor: 10.122

View more
  65 in total

1.  Nyctanthes arbor-tristis leaf extract ameliorates hyperlipidemia- and hyperglycemia-associated nephrotoxicity by improving anti-oxidant and anti-inflammatory status in high-fat diet-streptozotocin-induced diabetic rats.

Authors:  Sayed Adam Mousum; Sahabuddin Ahmed; Basveshwar Gawali; Mohit Kwatra; Anwaruddin Ahmed; Mangala Lahkar
Journal:  Inflammopharmacology       Date:  2018-06-01       Impact factor: 4.473

2.  Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion.

Authors:  Amit Bera; Falguni Das; Nandini Ghosh-Choudhury; Meenalakshmi M Mariappan; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  Am J Physiol Cell Physiol       Date:  2017-07-12       Impact factor: 4.249

3.  Regional variation of human pancreatic islets dimension and its impact on beta cells in Indian population.

Authors:  Praveen Kumar Ravi; Suvendu Purkait; Usha Agrawal; Susama Patra; Madhumita Patnaik; Sudipta Ranjan Singh; Pravash Ranjan Mishra
Journal:  Islets       Date:  2019-11-19       Impact factor: 2.694

Review 4.  Antidiabetic phytoconstituents and their mode of action on metabolic pathways.

Authors:  Sudhanshu Kumar Bharti; Supriya Krishnan; Ashwini Kumar; Awanish Kumar
Journal:  Ther Adv Endocrinol Metab       Date:  2018-02-12       Impact factor: 3.565

Review 5.  Effect of Chromium Supplementation on Blood Glucose and Lipid Levels in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis.

Authors:  Fengyi Zhao; Da Pan; Niannian Wang; Hui Xia; Hong Zhang; Shaokang Wang; Guiju Sun
Journal:  Biol Trace Elem Res       Date:  2021-03-30       Impact factor: 3.738

Review 6.  Contributive Role of Hyperglycemia and Hypoglycemia Towards the Development of Alzheimer's Disease.

Authors:  Riya Chakrabarty; Sumaira Yousuf; Mahendra P Singh
Journal:  Mol Neurobiol       Date:  2022-05-03       Impact factor: 5.590

7.  Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India.

Authors:  Deepu David; Anantharam Raghavendran; Ashish Goel; C Bharath Kumar; Thomas Alex Kodiatte; Deepak Burad; Priya Abraham; Banumathi Ramakrishna; Philip Joseph; Jeyamani Ramachandran; C E Eapen
Journal:  Indian J Gastroenterol       Date:  2017-10-04

Review 8.  Effects of diabetes on the development of radiation pneumonitis.

Authors:  Guangtong Dong; Yuxiao Li; Qiyao Zhao; Bing Pang; Xin Qi; Junping Wei; Wei Hou
Journal:  Respir Res       Date:  2021-05-24

9.  Guan Xin Dan Shen formulation protects db/db mice against diabetic cardiomyopathy via activation of Nrf2 signaling.

Authors:  Bin Zhang; Chen-Yang Zhang; Xue-Lian Zhang; Gui-Bo Sun; Xiao-Bo Sun
Journal:  Mol Med Rep       Date:  2021-05-26       Impact factor: 2.952

10.  Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management.

Authors:  Sambit Das; A K Gupta; Biplab Bandyopadhyaya; B Harish Darla; Vivek Arya; Mahesh Abhyankar; Santosh Revankar
Journal:  Bioinformation       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.